Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope.

Ressing ME, van Driel WJ, Celis E, Sette A, Brandt MP, Hartman M, Anholts JD, Schreuder GM, ter Harmsel WB, Fleuren GJ, Trimbos BJ, Kast WM, Melief CJ.

Cancer Res. 1996 Feb 1;56(3):582-8.

PMID:
8564975
[PubMed - indexed for MEDLINE]
Free Article
2.

T cell epitopes in human papilloma virus proteins.

Sadovnikova E, Stauss HJ.

Behring Inst Mitt. 1994 Jul;(94):87-93. Review.

PMID:
7528003
[PubMed - indexed for MEDLINE]
3.

Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.

Sasagawa T, Takagi H, Makinoda S.

J Infect Chemother. 2012 Dec;18(6):807-15. doi: 10.1007/s10156-012-0485-5. Epub 2012 Nov 3. Review.

PMID:
23117294
[PubMed - indexed for MEDLINE]
4.

Synthetic vaccine for the treatment of lesions caused by high risk human papilloma virus.

Melief CJ.

Cancer J. 2011 Sep-Oct;17(5):300-1. doi: 10.1097/PPO.0b013e318235e0fe. Review.

PMID:
21952279
[PubMed - indexed for MEDLINE]
5.

Treatment of established lesions caused by high-risk human papilloma virus using a synthetic vaccine.

Melief CJ.

J Immunother. 2012 Apr;35(3):215-6. doi: 10.1097/CJI.0b013e318248f17f. Review.

PMID:
22421938
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk